BioMarin to Host Investor Day Today at 10:30 a.m. Eastern Time

Rhea-AI Summary

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is hosting its Investor Day on September 4, 2024, in New York, starting at 10:30 a.m. Eastern Time. The event, led by President and CEO Alexander Hardy, will showcase the company's new strategic priorities aimed at delivering significant value creation.

Key presentations include:

• BioMarin's new corporate strategy for sustained value creation
• Financial strategy for high growth and superior returns
• Innovation strategy for a sustainable pipeline of high-impact medicines
• Commercial growth strategy, focusing on enzyme therapies and leadership in achondroplasia

The event will be accessible virtually, with a live webcast, replay, and presentation slides available on BioMarin's Investor Relations website for at least 12 months.

News Market Reaction

-1.89%

1 alert

-1.89% News Effect

On the day this news was published, BMRN declined 1.89%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

NEW YORK, Sept. 4, 2024 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) will host its Investor Day today in New York.  The event begins at 10:30 a.m. Eastern Time and can be accessed virtually here. 

Led by President and Chief Executive Officer Alexander Hardy, the event will feature presentations from BioMarin's leadership team as they introduce strategic priorities that underscore BioMarin's commitment to deliver significant value creation. A question-and-answer session will follow prepared remarks. 

BioMarin's Investor Day Agenda:

• BioMarin's New Corporate Strategy to Deliver Significant and Sustained Value Creation to Stakeholders
  Alexander Hardy, President and Chief Executive Officer
  
  
• Value Commitment: Financial Strategy to Deliver High Growth and Superior Returns
  Brian Mueller, Executive Vice President, Chief Financial Officer
  
  
• Innovation Strategy to Deliver Sustainable Pipeline of High Impact Medicines
  Hank Fuchs, M.D., President, Worldwide R&D
  
  
• Commercial Growth Strategy:
  • o   Optimizing BioMarin's Growing and Durable Enzyme Therapies Business Unit
  • o   Building Leadership in Achondroplasia to Set the Stage for Multiple New Indications
    
    Cristin Hubbard, Executive Vice President, Chief Commercial Officer

A link to the live webcast, replay and presentation slides will be available on BioMarin's Investor Relations website for at least 12 months at investors.biomarin.com.

About BioMarin
Founded in 1997, BioMarin is a global biotechnology Company dedicated to transforming lives through genetic discovery. The Company develops and commercializes targeted therapies that address the root cause of genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The Company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit www.biomarin.com.

Contacts:
Investors	Media
Traci McCarty	Marni Kottle
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(415) 218-7111

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-host-investor-day-today-at-1030-am-eastern-time-302237727.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When is BioMarin (BMRN) hosting its Investor Day in 2024?

BioMarin (BMRN) is hosting its Investor Day on September 4, 2024, starting at 10:30 a.m. Eastern Time in New York.

What key topics will be covered during BioMarin's (BMRN) Investor Day?

BioMarin's Investor Day will cover the company's new corporate strategy, financial strategy for high growth, innovation strategy for pipeline development, and commercial growth strategy focusing on enzyme therapies and achondroplasia leadership.

How can investors access BioMarin's (BMRN) Investor Day event?

Investors can access BioMarin's Investor Day event virtually through a live webcast. A replay and presentation slides will be available on BioMarin's Investor Relations website for at least 12 months.

Who will be leading the presentations at BioMarin's (BMRN) Investor Day?

The presentations at BioMarin's Investor Day will be led by President and CEO Alexander Hardy, along with other key executives including Brian Mueller (CFO), Hank Fuchs (President of Worldwide R&D), and Cristin Hubbard (Chief Commercial Officer).